Definitely a big WOW! Compelling argument why statins with their pleiotropic effects are still needed with a PCSK9i. Reducing inflammation by targeting Lp(a), APOC3, and/or ANGPTL3 appears to be the "better" approach to reduce CV risk. $IONS $ARWR $AMGN $AKCA $PFE $NVS https://t.co/QM5LEaytrZ